Atogepant

阿托吉泮

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameAtogepant
Drug Alias NameImidazoazepanesCGRP receptor antagonistsgepantQuliptaAquipta +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcitonin gene-related peptide receptor antagonists
TargetsCalcitonin gene-related peptide receptor
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsMigraine Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/09/28
Country/TerritoryCzechiaBelgiumCanada +[27] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesForest Laboratories Ireland LtdAllergan PlcAbbvie Ag +[9] 
Inactive CompaniesN/A
Active IndicationsMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN02CD07
Related LinksWikipediaDrugBankKEGG